Millennium Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,608,882
| Closed | -$34.3M | – | 6733 |
|
|
2024
Q1 | $34.3M | Buy |
1,608,882
+1,030,780
| +178% | +$12.3M | 0.01% | 1090 |
|
|
2023
Q4 | $5.56M | Sell |
578,102
-4,027
| -0.7% | -$19.6K | ﹤0.01% | 2699 |
|
|
2023
Q3 | $1.51M | Buy |
582,129
+247,552
| +74% | +$794K | ﹤0.01% | 3829 |
|
|
2023
Q2 | $1.56M | Sell |
334,577
-69,211
| -17% | -$299K | ﹤0.01% | 3689 |
|
|
2023
Q1 | $1.47M | Buy |
+403,788
| New | +$1.59M | ﹤0.01% | 3731 |
|
|
2022
Q3 | – | Sell |
-11,722
| Closed | -$29K | – | 7621 |
|
|
2022
Q2 | $29K | Buy |
+11,722
| New | +$53.9K | ﹤0.01% | 6384 |
|
|
2021
Q4 | – | Sell |
-26,925
| Closed | -$213K | – | 7530 |
|
|
2021
Q3 | $213K | Buy |
+26,925
| New | +$227K | ﹤0.01% | 6076 |
|
|
2021
Q2 | – | Sell |
-10,726
| Closed | -$115K | – | 7267 |
|
|
2021
Q1 | $115K | Sell |
10,726
-35,784
| -77% | -$418K | ﹤0.01% | 5667 |
|
|
2020
Q4 | $546K | Sell |
46,510
-136,202
| -75% | -$1.71M | ﹤0.01% | 4123 |
|
|
2020
Q3 | $2.2M | Sell |
182,712
-27,789
| -13% | -$380K | ﹤0.01% | 2528 |
|
|
2020
Q2 | $3.68M | Buy |
+210,501
| New | +$3.67M | 0.01% | 2046 |
|
Millennium Management's FUSN Position: Q2 2024 in Review
Millennium Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 1,608,882 shares — an estimated $34.3M sold.
Millennium Management first reported a position in FUSN in Q2 2020 and held it in 11 quarters. The position peaked at $34.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.
- Millennium Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
- Millennium Management sold 1,608,882 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $34.3M.
- Millennium Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 11 quarters.
- Millennium Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $34.3M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.